Grandview Asset Management’s Idexx Laboratories IDXX Stock Holding History

Grandview Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-108	Closed	-$53K	–	257
2021 Q1	$53K	Buy	+108	New	+$54.1K	0.03%	198
2020 Q1	–	Sell	-3,518	Closed	-$932K	–	45
2019 Q4	$932K	Sell	3,518 -285	-7%	-$75.1K	0.88%	30
2019 Q3	$1.02M	Buy	3,803 +159	+4%	+$44.2K	0.93%	31
2019 Q2	$1M	Sell	3,644 -190	-5%	-$46.8K	0.93%	29
2019 Q1	$857K	Buy	3,834 +75	+2%	+$15.5K	0.79%	37
2018 Q4	$699K	Buy	+3,759	New	+$771K	0.74%	39

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Grandview Asset Management's IDXX Position: Q2 2021 in Review

Grandview Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2021, closing a stake of 108 shares — an estimated $53K sold.

Grandview Asset Management first reported a position in IDXX in Q4 2018 and held it in 6 quarters. The position peaked at $1.02M in Q3 2019. 1,034 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

Grandview Asset Management reported no remaining Idexx Laboratories position as of Q2 2021 after selling out during the quarter.
Grandview Asset Management sold 108 Idexx Laboratories shares in Q2 2021, an estimated $53K.
Grandview Asset Management first reported a position in Idexx Laboratories in Q4 2018 and held it in 6 quarters.
Grandview Asset Management's Idexx Laboratories position peaked at $1.02M in Q3 2019.
1,034 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on Grandview Asset Management's 13F filing for Q2 2021, filed 21 Jul 2021.